Balance sheet of Sotac Pharmaceutical is moderately strong, But short term working capital might become an issue for this company.

The net debt of Sotac Pharmaceutical is decreasing.
Latest net debt of Sotac Pharmaceutical is ₹36.04 Crs as of Sep-25.
This is less than Mar-25 when it was ₹40.95 Crs.

Yes, profit is increasing.
The profit of Sotac Pharmaceutical is ₹8.03 Crs for Mar 2025, ₹4.28 Crs for Mar 2024 and ₹2.88 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sotac Pharmaceutical latest dividend payout ratio is 1.38% and 3yr average dividend payout ratio is 1.38%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable